Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
ONCOTICE BCG 5 hundred million CFU powder for injection vial AUST R: 59912 Active ingredients: Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) Dosage form: Injection, powder for Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd Phone: 1800818553	From 01 Jan 2019 to 31 Dec 2026	Shortage status: Current Availability: Limited Availability Reason: Unexpected increase in consumer demand Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Product details

Supply Impact Dates

Further Details

ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Active ingredients:
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)

Dosage form:
Injection, powder for

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800818553

From
01 Jan 2019
to
31 Dec 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.